Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancerROYCHOWDHURY, Debasish; LAHN, Michael.Seminars in oncology. 2003, Vol 30, Num 2, pp 30-33, issn 0093-7754, 4 p., SUP3Article

A report on serious pulmonary toxicity associated with gemcitabine-based therapyROYCHOWDHURY, Debasish F; CASSIDY, Catherine A; PETERSON, Patrick et al.Investigational new drugs. 2002, Vol 20, Num 3, pp 311-315, issn 0167-6997Article

Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer : A phase II trial of the southwest oncology groupKELLY, Karen; LOVATO, Laura; BUNN, Paul A et al.Clinical cancer research. 2001, Vol 7, Num 8, pp 2325-2329, issn 1078-0432Article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analysesCAMERON, David; CASEY, Michelle; CHAN, Arlene et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 533-543, issn 0167-6806, 11 p.Article

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura : a randomised, double-blind, placebo-controlled trialBUSSEL, James B; PROVAN, Drew; STONE, Nicole et al.Lancet (British edition). 2009, Vol 373, Num 9664, pp 641-648, issn 0140-6736, 8 p.Article

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast CancerLIN, Nancy U; DIERAS, Véronique; LOIBL, Sibylle et al.Clinical cancer research (Print). 2009, Vol 15, Num 4, pp 1452-1459, issn 1078-0432, 8 p.Article

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III TrialSTERNBERG, Cora N; DAVIS, Ian D; ZARBA, Juan J et al.Journal of clinical oncology. 2010, Vol 28, Num 6, pp 1061-1068, issn 0732-183X, 8 p.Article

Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non-Small-Cell Lung CancerALTORKI, Nasser; LANE, Maureen E; MITCHELL, John D et al.Journal of clinical oncology. 2010, Vol 28, Num 19, pp 3131-3137, issn 0732-183X, 7 p.Article